Category stocks

Carnival Expects $2.22 Earnings Per Share

Carnival forecasts $2.22 EPS for 2026 Carnival Corporation expects to earn $2.22 per share in 2026. The company also outperformed its March guidance by $100 million. Customer deposits reached an all-time high of $9 billion. Yields exceeded expectations due to resili

Regeneron Therapy Under Review

Regeneron's myasthenia gravis therapy is under US and EU review Regeneron's experimental therapy, cemdisiran, is being reviewed by US and European regulators. The therapy, developed with Alnylam Pharmaceuticals, is for the rare autoimmune condition myasthenia gravi